Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

BACKGROUND: This prospective study investigated the superiority of transarterial chemoembolization (TACE) with miriplatin over TACE with epirubicin regarding overall survival (OS) in patients with unresectable hepatocellular carcinoma (HCC). METHODS: Patients with unresectable HCC were randomized 1:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Masafumi, Kudo, Masatoshi, Aikata, Hiroshi, Nagamatsu, Hiroaki, Ishii, Hiroshi, Yokosuka, Osamu, Torimura, Takuji, Morimoto, Manabu, Ikeda, Kenji, Kumada, Hiromitsu, Sato, Tosiya, Kawai, Ikuko, Yamashita, Toru, Horio, Hiroshi, Okusaka, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846877/
https://www.ncbi.nlm.nih.gov/pubmed/28766016
http://dx.doi.org/10.1007/s00535-017-1374-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846877/
https://www.ncbi.nlm.nih.gov/pubmed/28766016
http://dx.doi.org/10.1007/s00535-017-1374-6

Ejemplares similares